Jiequn Ma

No. 277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Targeting acetylcholine: a novel strategy for treating lung adenocarcinoma.

Targeting acetylcholine: a novel strategy for treating lung adenocarcinoma.

Journal: BMC medical genomics
Published: February 25, 2026

Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review).

Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review).

Journal: Oncology reports
Published: May 28, 2025

Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for NTRK3 fusion.

Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for NTRK3 fusion.

Journal: Frontiers in oncology
Published: March 06, 2025

Immunotherapy for primary squamous cell carcinoma of the liver: A case report.

Immunotherapy for primary squamous cell carcinoma of the liver: A case report.

Journal: Oncology letters
Published: December 14, 2024

Complete remission after pembrolizumab monotherapy in a non-small cell lung cancer patient with PD-L1 negative, high tumor mutational burden, and positive tumor-infiltrating lymphocytes: A case report.

Complete remission after pembrolizumab monotherapy in a non-small cell lung cancer patient with PD-L1 negative, high tumor mutational burden, and positive tumor-infiltrating lymphocytes: A case report.

Journal: Medicine
Published: December 10, 2024

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 18, 2023

Colon cancer cells secreted CXCL11 via RBP-Jκ to facilitated tumour-associated macrophage-induced cancer metastasis.

Colon cancer cells secreted CXCL11 via RBP-Jκ to facilitated tumour-associated macrophage-induced cancer metastasis.

Journal: Journal of cellular and molecular medicine
Published: February 03, 2021

MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC.

MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC.

Journal: Oncology research
Published: November 13, 2019

Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.

Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.

Journal: Cancer science
Published: March 12, 2018

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 11, 2017

High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma.

High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma.

Journal: Breast cancer : basic and clinical research
Published: June 04, 2015

Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.

Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.

Journal: Molecular medicine reports
Published: March 08, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026